Location History:
- Wellesly, MA (US) (2014)
- Wellesley, MA (US) (2012 - 2021)
Company Filing History:
3 out of 16 
1 out of 34 
3 out of 832,880 Years Active: 2012-2021
Title: The Innovative Contributions of Martin Andrew Acquadro
Introduction
Martin Andrew Acquadro is a notable inventor based in Wellesley, MA, with a significant portfolio of seven patents. His work primarily focuses on advancements in medical technology, particularly in the field of monitoring brainstem activity through eye movement analysis.
Latest Patents
Among his latest patents is a method for measuring sedation using ocular microtremor (OMT) and microsaccades (MS). This invention features an eye sensor designed to measure fixational eye movements of an individual's eyeball, providing a variable voltage biosignal that reflects the individual's brainstem activity. The sensor is mounted on the individual's eyelid, allowing it to detect subtle eye movements. The biosignal generated is transmitted to an amplifier located on the skin, where it is amplified and processed. This system enables anesthesiologists and clinicians to access graphical and numerical representations of the biosignal, facilitating better patient monitoring. Another significant patent is the ocular microtremor (OMT) sensor, which employs a similar methodology to measure eye movements and analyze brainstem activity.
Career Highlights
Throughout his career, Acquadro has made substantial contributions to the field of medical technology. He has worked with various organizations, including Botulinum Toxin Research Associates, Inc., where he has furthered his research and development efforts.
Collaborations
Acquadro has collaborated with notable professionals in his field, including Gary E. Borodic and Michael Baltay. Their combined expertise has likely contributed to the success of his innovative projects.
Conclusion
Martin Andrew Acquadro's work exemplifies the intersection of technology and medicine, showcasing his commitment to improving patient care through innovative inventions. His patents reflect a deep understanding of the complexities of brain activity and the potential for non-invasive monitoring techniques.